Anakinra in Hidradenitis Suppurativa

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Hidradenitis Suppurativa
Interventions
DRUG

Water for injection

Placebo syringes will contain 0.67ml of sterile water for injection. This will be injecteda daily for 12 weeks.

DRUG

Anakinra

Anakinra will be supplied in single use pre-filed glass syringes with 27-gauge needles. Anakinra syringe will contain 100mg of anakinra at a volume of 0.67 ml. This will be injected subcutaneously daily for 12 weeks.

Trial Locations (2)

12462

2nd Department of Dermatology, ATTIKON University Hospital, Athens

4th Department of Internal Medicine, ATTIKON University Hospital, Athens

All Listed Sponsors
lead

University of Athens

OTHER

NCT01558375 - Anakinra in Hidradenitis Suppurativa | Biotech Hunter | Biotech Hunter